ABCG2 and hepatocellular carcinoma: ABCG2-positive cells from hepatocellular carcinoma (HCC), displayed enhancements in tumorigenicity, proliferation capacity, doxorubicin resistance, cell migration, and invasion potential, whereas ABCG2 down-expression by siRNA significantly blocked these malignant properties [7].